Turmeric References - Section iv

  1. Dairam, Amichaud. An Investigation into the Neuroprotective Properties of the Non-Steroidal Anti-Inflammatory Agents Tolmetin, Sulindac and Turmeric. Pharmacy. Grahamstown: Rhodes University. 2006. Thesis.
  2. Pharmacological and clinical properties of curcumin. Beevers, Christopher S. and Huang, Shile. [ed.] Ayse Kuruuzum-Uz. Ankara: Dove Medical Press Ltd., June 23, 2011, Botanics: Targets and Therapy, Vol. 1, pp. 5-18. DOI: 10.2147/BTAT.S17244; http://www.dovepress.com/pharmacological-and-clinical-properties-of-curcumin-peer-reviewed-article-BTAT. ISSN: 1179-9897.
  3. Neuroprotection by Spice-Derived Nutraceuticals: You Are What You Eat! Kannappan, Ramaswamy, et al., et al. [ed.] Nicolas G. Bazan. 2, New Orleans: Springer Science+Business Media, LLC, October 1, 2011, Molecular Neurobiology, Vol. 44, pp. 142-159. DOI: 10.1007/s12035-011-8168-2; http://link.springer.com/article/10.1007%2Fs12035-011-8168-2. ISSN: 0893-7648.
  4. Sarker, Satyajit D. and Nahar, Lutfun. Bioactivity of Turmeric. [ed.] P. N. Ravindran, K. Nirmal Babu and K. Sivaraman. Turmeric: The Genus Curcuma. Boca Raton: CRC Press: Taylor & Francis Group, LLC, 2007, 9, pp. 258-285. ISBN-13: 978-0-8493-7034-2.
  5. Sun, Albert Y., et al., et al. Botanical Phenolics and Neurodegeneration. [ed.] Iris F. F. Benzie and Sissi Wachtel-Galor. Herbal Medicine: Biomolecular and Clinical Aspects. 2nd. Boca Raton: CRC Press: Taylor and Francis Group, LLC,2011, Vol. 28 of Oxidative Stress and Disease, 15, pp. 315-332. ISBN: 978-1-4398-0713-2.
  6. Aggarwal, Bharat B., Harikumar, Kuzhuvelil B. and Dey, Sanjit. Prevention and Treatment of Neurodegenerative Diseases by Spice-Derived Phytochemicals. [ed.] Lester Packer, et al., et al. Micronutrients and Brain Health. Boca Raton: CRC Press: Taylor and Francis Group, LLC, 2010, 20, pp. 281-308. ISBN: 978-1-4200-7351-5.
  7. Xu, Ying, Zhang, Chong and Ogle, William O. The Serotonergic System and Neuroplasticity are Implicated in the Effect of Phytochemicals on Mood and Cognitive Disorders. [ed.] Haixue Kuang. Recent Advances in Theories and Practice of Chinese Medicine. s.l.: InTech — Open Access Company, 2012, 15, pp. 291-312. ISBN: 978-953-307-903-5.
  8. Neuroprotective Effects Of Curcumin. Nabiuni, M., et al., et al. [ed.] Abdel Rahman Mohammad Said Al-Tawaha. 9, Amman: American-Eurasian Network for Scientific Information, September 2011, Australian Journal of Basic and Applied Sciences, Vol. 5, pp. 2224-2240. ISSN: 1991-8178.
  9. Ehrlich, Steven D. Dementia. University of Maryland Medical Center. [Online] May 7, 2013. [Cited: March 3, 2015.] http://www.umm.edu/altmed/articles/dementia-000046.htm.
  10. Epigenetic mechanisms in human physiology and diseases. Korkmaz, Ahmet, et al., et al. [ed.] Sukru Oter. 3, Ankara: Dr. Coskun Akay, June 1, 2011, Journal of Experimental and Integrative Medicine, Vol. 1, pp. 139-147. DOI: 10.5455/jeim.060611.rw.003; http://www.scopemed.org/?mno=5998. ISSN: 1309-4572.
  11. Cole, Greg M., Teter, Bruce and Frautschy, Sally A. Neuroprotective Effects of Curcumin. [ed.] Bharat B. Aggarwal, Young-Joon Surh and Shishir Shishodia. [ed.] Bharat B. Aggarwal, Young-Joon Surh and Shishir Shishodia. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease. New York: Springer Science+Business Media, LLC, 2007, pp. 197-212. ISBN-13: 978-0-387-46400-8.
  12. Curcumin attenuates diabetic encephalopathy in rats: behavioral and biochemical evidences. Kuhad, Anurag and Chopra, Kanwaljit. [ed.] W.H. Gispen and F.P. Nijkamp. 1-3, Utrecht: Elsevier B.V., December 8, 2007, European Journal of Pharmacology, Vol. 576, pp. 34-42. DOI: 10.1016/j.ejphar.2007.08.001; http://www.sciencedirect.com/science/article/pii/S0014299907008916. ISSN: 0014-2999.
  13. Oxidative stress and hippocampus in a low-grade hepatic encephalopathy model: protective effects of curcumin. Roselló, Diego Martin, et al., et al. [ed.] Tetsuo Takehara. 11, Osaka: John Wiley & Sons, Inc.: The Japan Society of Hepatology, November 2008, Hepatology Research, Vol. 38, pp. 1148-1153. DOI: 10.1111/j.1872-034X.2008.00377.x; http://onlinelibrary.wiley.com/doi/10.1111/j.1872-034X.2008.00377.x/abstract. eISSN: 1872-034X.
  14. Baugh, Nikkisha Antoinette. Effects of Curcumin on a C57BL/6J mouse model of thiamine deficiency induced Wernicke-Korsakoff Syndrome. Neuroscience. Wooster: The College of Wooster, 2012. Senior Independent Study Theses. Paper 65.
  15. Curcumin binds to the alpha-helical intermediate and to the amyloid form of prion protein - a new mechanism for the inhibition of PrP(Sc) accumulation. Hafner-Bratkovič, Iva, et al., et al. [ed.] Jörg Schulz. 6, Aachen: John Wiley & Sons, Inc.: International Society for Neurochemistry, March 2008, Journal of Neurochemistry, Vol. 104, pp. 1553-1564. DOI: 10.1111/j.1471-4159.2007.05105.x; http://onlinelibrary.wiley.com/doi/10.1111/j.1471-4159.2007.05105.x/abstract. eISSN: 1471-4159.
  16. Evaluation of drugs for treatment of prion infections of the central nervous system. Riemer, Constanze, et al., et al. [ed.] Richard M. Elliott. 2, St. Andrews: Society for General Microbiology, February 2008, Journal of General Virology, Vol. 89, pp. 594-597. DOI: 10.1099/vir.0.83281-0; http://vir.sgmjournals.org/content/89/2/594. ISSN: 0022-1317.
  17. GABAergic and nitriergic modulation by curcumin for its antianxiety-like activity in mice. Gilhotra, Neeraj and Dhingra, Dinesh. [ed.] Floyd E. Bloom. La Jolla: Elsevier B.V., September 17, 2010, Brain Research, Vol. 1352, pp. 167-175. DOI: 10.1016/j.brainres.2010.07.007; http://www.sciencedirect.com/science/article/pii/S0006899310015337. ISSN: 0006-8993.
  18. Possible nitric oxide modulation in protective effect of (Curcuma longa, Zingiberaceae) against sleep deprivation-induced behavioral alterations and oxidative damage in mice. Kumar, Anil and Singh, Anant. [ed.] Hildebert Wagner. 8, München: Elsevier GmbH: Urban and Fischer, August 1, 2008, Phytomedicine, Vol. 15, pp. 577-586. DOI: 10.1016/j.phymed.2008.02.003; http://www.sciencedirect.com/science/article/pii/S0944711308000196. ISSN: 0944-7113.
  19. Analgesic Effects of Intrathecal Curcumin in the Rat Formalin Test. Han, Yong Ku, et al., et al. [ed.] Kyung Hoon Kim. 1, Busan: The Korean Pain Society, January 2012, The Korean Journal of Pain, Vol. 25, pp. 1-6. DOI: 10.3344/kjp.2012.25.1.1; http://synapse.koreamed.org/DOIx.php?id=10.3344/kjp.2012.25.1.1. ISSN: 2005-9159.
  20. Brinker, Francis F. Enhancing Anti-Inflammatory Drug Effects with Botanicals. [ed.] David P. Rakel and Nancy Faass. Complementary Medicine in Clinical Practice: Integrative Practice In American Healthcare. Ontario: Jones and Bartlett Publishers, Inc., 2006, 61, pp. 445-458. ISBN-13: 978-0-7637-3065-9.
  21. Danette C. Taylor Pain Management: Neuropathic Pain. MedicineNet. [Online] December 11, 2013. [Cited: March 3, 2015.] http://www.medicinenet.com/neuropathic_pain_nerve_pain/article.htm.
  22. Dietary Curcumin Supplementation Counteracts Reduction in Levels of Molecules Involved in Energy Homeostasis after Brain Trauma. Sharma, S., et al., et al. [ed.] Stephen G. Lisberger. 4, Durham: Elsevier Ltd., July 21, 2009, Neuroscience, Vol. 161, pp. 1037-1044. DOI: 10.1016/j.neuroscience.2009.04.042; http://www.sciencedirect.com/science/article/pii/S0306452209006496. ISSN: 0306-4522.
  23. Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Wilken, Reason, et al., et al. [ed.] Christophe Nicot and Alan Storey. 12, Kansas City; Oxford: Biomed Central Ltd., February 7, 2011, Molecular Cancer, Vol. 10, pp. 1-57. DOI: 10.1186/1476-4598-10-12; http://www.molecular-cancer.com/content/10/1/12#. ISSN: 1476-4598.
  24. Neuroprotective efficacy and therapeutic window of curcuma oil: in rat embolic stroke model. Dohare, Preeti, et al., et al. [ed.] Thomas A. Rowles. 55, London: BioMed Central Ltd., September 30, 2008, BMC Complementary and Alternative Medicine, Vol. 8. DOI: 10.1186/1472-6882-8-55; http://www.biomedcentral.com/1472-6882/8/55. ISSN: 1472-6882.
  25. Anti-ischemic Effect of Curcumin in Rat Brain. Shukla, Pradeep K., et al., et al. [ed.] Abel Lajtha. 6, New York: Springer US, June 1, 2008, Neurochemical Research, Vol. 33, pp. 1036-1043. DOI: 10.1007/s11064-007-9547-y; http://link.springer.com/article/10.1007%2Fs11064-007-9547-y. ISSN: 0364-3190.
  26. The combined effects of exercise and foods in preventing neurological and cognitive disorders. Gomez-Pinilla, Fernando. [ed.] Alfredo Morabia. Supplement 1, New York: Elsevier Inc., June 1, 2011, Preventive Medicine, Vol. 52, pp. S75-S80. DOI: 10.1016/j.ypmed.2011.01.023; http://www.sciencedirect.com/science/article/pii/S009174351100051X. ISSN: 0091-7435.
  27. An Overview of Curcumin in Neurological Disorders. Kulkarni, S.K. and Dhir, A. [ed.] Rao V.S.V. Vadlamudi. 2, Vidyanagar: Wolters Kluwer Health: Medknow, Mar-Apr 2010, Indian Journal of Pharmaceutical Sciences, Vol. 72, pp. 149-154. DOI: 10.4103/0250-474X.65012; http://www.ijpsonline.com/article.asp?issn=0250-474X;year=2010;volume=72;issue=2;spage=149;epage=154;aulast=Kulkarni. ISSN: 0250-474X.
  28. Mood Disorders - Psychoneuroimmunology Meets Neuropsychopharmacology: Translational Implications of the Impact of Inflammation on Behavior. Haroon, Ebrahim, Raison, Charles L. and Miller, Andrew H. [ed.] Peter Kalivas and Gwenn S. Smith. 1, s.l.: Nature Publishing Group: American College of Neuropsychopharmacology, January 2012, Neuropsychopharmacology Reviews, Vol. 37, pp. 137–162. DOI: 10.1038/npp.2011.205; http://www.nature.com/npp/journal/v37/n1/full/npp2011205a.html. ISSN: 0893-133X.
  29. Reactive astrocytes as therapeutic targets for CNS disorders. Hamby, Mary E. and Sofroniew, Michael V. [ed.] Alan I. Faden. 4, Baltimore: Elsevier, October 1, 2010, Neurotherapeutics, Vol. 7, pp. 494-506. DOI: 10.1016/j.nurt.2010.07.003; http://link.springer.com/article/10.1016%2Fj.nurt.2010.07.003. ISSN: 1933-7213.
  30. Natural plant products and extracts that reduce immunoexcitotoxicity-associated neurodegeneration and promote repair within the central nervous system. Blaylock, Russell L. and Maroon, Joseph. [ed.] James I. Ausman. 19, Los Angeles: Medknow, February 15, 2012, Surgical Neurology International®, Vol. 3. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3307240/. ISSN: 2152-7806.
  31. Molecular mechanisms for anti-aging by natural dietary compounds. Pan, Min-Hsiung, et al., et al. [ed.] Hans-Ulrich Humpf. 1, Weinheim: WILEY-VCH Verlag GmbH & Co. KGaA, January 2012, Molecular Nutrition & Food Research, Vol. 56, pp. 88-115. DOI: 10.1002/mnfr.201100509; http://onlinelibrary.wiley.com/doi/10.1002/mnfr.201100509/abstract. ISSN: 1613-4133.
  32. Freye, Enno. Representative Ailments with Excess Nitric Oxide Formation. Acquired Mitochondropathy - A New Paradigm in Western Medicine Explaining Chronic Diseases. Dordrecht: Springer Science+Business Media, 2012, 5, pp. 37-54. ISBN: 978-94-007-2035-0.
  33. Curcumin reduces α-synuclein induced cytotoxicity in Parkinson's disease cell model. Wang, Min S., et al., et al. [ed.] Melissa Norton. 57, St. Louis: BioMed Central Ltd., April 30, 2010, BMC Neuroscience, Vol. 11. DOI: 10.1186/1471-2202-11-57; http://www.biomedcentral.com/1471-2202/11/57. eISSN: 1471-2202.
  34. Balakrishnan, K.V. Postharvest Technology and Processing of Turmeric. [ed.] P. N. Ravindran, K. Nirmal Babu and K. Sivaraman. Turmeric: The Genus Curcuma. Boca Raton: CRC Press: Taylor & Francis Group, LLC, 2007, 8, pp. 193-256. ISBN-13: 978-0-8493-7034-2.
  35. Attokaran, Mathew. Turmeric: Curcuma longa L (Zingiberaceae). Natural Food Flavors and Colorants. Ames: Blackwell Publishing Ltd. and Institute of Food Technologists, 2011, 98, pp. 391-398. ISBN: 978-0-8138-2110-8.
  36. Khan, Nasiruddin, et al., et al. Resveratrol and Bioactive Flavonoids in Immune Function. [ed.] Ronald Ross Watson, Sherma Zibadi and Victor R. Preedy. Dietary Components and Immune Function. New York: Springer Science+Business Media, LLC, 2010, 23, pp. 397-420. ISBN: 978-1-60761-061-1; DOI: 10.1007/978-1-60761-061-8.
  37. Braun, Lesley and Cohen, Marc. Herbs & Natural Supplements: An Evidence-Based Guide. Marrickville: Elsevier Australia, 2007. ISBN-13: 978-0-7295-3796-4.
  38. Nahar, Lutfun and Sarker, Satyajit D. Phytochemistry of the Genus Curcuma. [ed.] P. N. Ravindran, K. Nirmal Babu and K. Sivaraman. Turmeric: The Genus Curcuma. Boca Raton: CRC Press: Taylor & Francis Group, LLC, 2007, 3, pp. 71-106. ISBN-13: 978-0-8493-7034-2.
  39. The Biochemical and Cellular Basis for Nutraceutical Strategies to Attenuate Neurodegeneration in Parkinson's Disease. Mazzio, Elizabeth A., Close, Fran and Soliman, Karam F.A. [ed.] Andrei Alexandrescu. 1, Storrs: MDPI AG, January 17, 2011, International Journal of Molecular Sciences, Vol. 12, pp. 506-569. DOI: 10.3390/ijms12010506; http://www.mdpi.com/1422-0067/12/1/506. ISSN: 1422-0067.
  40. USDA Database for Standard Reference. NutriBase 7 Clinical Edition. s.l.: CyperSoft, 2007.
  41. Phytochemical flavonols, carotenoids and the antioxidant properties of a wide selection of Fijian fruit, vegetables and other readily available foods. Lako, Jimaima, et al., et al. [ed.] G.G. Birch. 4, Reading: Elsevier Ltd., 2007, Food Chemistry, Vol. 101, pp. 1727-1741. DOI: 10.1016/j.foodchem.2006.01.031; http://www.sciencedirect.com/science/article/pii/S0308814606000872. ISSN: 0308-8146.
  42. Fernstrom, J.D. and Fernstrom, M.H. Brain and Nervous System. [ed.] Benjamin Caballero, Lindsay Allen and Andrew Prentice. Encyclopedia of Human Nutrition. 2. Oxford: Elsevier, Ltd., 2005, Vol. I, pp. 225-232. ISBN: 0-12-150110-8.
  43. Metals, oxidative stress and neurodegenerative disorders. Jomova, Klaudia, et al., et al. [ed.] Naranjan S. Dhalla. 1-2, Winnipeg: Springer Science+Business Media, December 1, 2010, Molecular and Cellular Biochemistry, Vol. 345, pp. 91-104. DOI: 10.1007/s11010-010-0563-x; http://link.springer.com/article/10.1007%2Fs11010-010-0563-x. ISSN: 0300-8177.
  44. Chempakam, B. and Parthasarathy, V.A. Turmeric. [ed.] V.A. Parthasarathy, B. Chempakam and T. John Zachariah. Chemistry of Spices. Oxfordshire: CAB International, 2008, 6, pp. 97-123. ISBN: 978-1-84593-405-7.
  45. Curcumin Structure-Function, Bioavailability, and Efficacy in Models of Neuroinflammation and Alzheimer's Disease. Begum, Aynun N., et al., et al. [ed.] Rick G. Schnellmann. 1, Columbia: American Society for Pharmacology and Experimental Therapeutics, July 2008, Journal of Pharmacology and Experimental Therapeutics, Vol. 326, pp. 196-208. DOI: 10.1124/jpet.108.137455; http://jpet.aspetjournals.org/content/326/1/196. ISSN: 0022-3565.
  46. Calabrese, Vittorio, et al., et al. Phenolics in Aging and Neurodegenerative Disorders. [ed.] Cesar G. Fraga. Plant Phenolics and Human Health: Biochemistry, Nutrition, and Pharmacology. Hoboken: John Wiley & Sons, Inc., 2010, 18, pp. 427-452. ISBN: 978-0-470-28721-7.
  47. Redox regulation of heat shock protein expression in aging and neurodegenerative disorders associated with oxidative stress: A nutritional approach. Calabrese, V., et al., et al. [ed.] Gert Lubec. 3-4, Vienna: Springer-Verlag, December 1, 2003, Amino Acids, Vol. 25, pp. 437-444. DOI: 10.1007/s00726-003-0048-2; http://link.springer.com/article/10.1007%2Fs00726-003-0048-2. ISSN: 0939-4451.
  48. Strayer, David S. and Rubin, Emanuel. Cell Adaptation, Cell Injury and Cell Death. [ed.] Raphael Rubin, David S. Strayer and Emanuel Rubin. Rubin's Pathology: Clinicopathologic Foundations of Medicine. 6. Philadelphia: Wolters Kluwer: Lippincott Williams & Wilkins, 2012, 1, pp. 1-46. ISBN: 978-1-60547-968-2.
  49. Ramiro-Puig, Emma, et al., et al. Food Antioxidants and Alzheimer’s Disease. [ed.] Lester Packer, et al., et al. Micronutrients and Brain Health. Boca Raton: CRC Press: Taylor and Francis Group, LLC, 2010, 4, pp. 41-50. ISBN: 978-1-4200-7351-5.
  50. Curcumin Decreases Amyloid-β Peptide Levels by Attenuating the Maturation of Amyloid-β Precursor Protein. Zhang, Can, et al., et al. [ed.] Herbert Tabor. 37, Bethesda: American Society for Biochemistry and Molecular Biology, Inc., September 10, 2010, The Journal of Biological Chemistry, Vol. 285, pp. 28472-28480. DOI: 10.1074/jbc.M110.133520; http://www.jbc.org/content/285/37/28472. ISSN: 0021-972X.
  51. Hartman, Richard E. Actions of Bioactive Phytochemicals in Cell Function and Alzheimer’s Disease Pathology. [ed.] Lester Packer, et al., et al. Micronutrients and Brain Health. Boca Raton: CRC Press: Taylor and Francis Group, LLC, 2010, 16, pp. 225-242. ISBN: 978-1-4200-7351-5.
  52. Development of Tau Aggregation Inhibitors for Alzheimer's Disease. Bulic, Bruno, et al., et al. [ed.] Peter Gölitz. 10, Weinheim: Wiley-VCH Verlag GmbH & Co., February 2, 2009, Angewandte Chemie International Edition, Vol. 48, pp. 1740-1752. DOI: 10.1002/anie.200802621; http://onlinelibrary.wiley.com/doi/10.1002/anie.200802621/abstract. eISSN: 1521-3773.
  53. Evaluating potential of curcumin loaded solid lipid nanoparticles in aluminium induced behavioural, biochemical and histopathological alterations in mice brain. Kakkar, Vandita and Kaur, Indu Pal. [ed.] A. Wallace Hayes. 11, Andover: Elsevier Inc., November 2011, Food and Chemical Toxicology, Vol. 49, pp. 2906-2913. DOI: 10.1016/j.fct.2011.08.006; http://www.sciencedirect.com/science/article/pii/S0278691511004108. ISSN: 0278-6915.
  54. Maczurek, Annette E., et al., et al. Lipoic Acid as a Novel Treatment for Mild Cognitive Impairment and Early-Stage Alzheimer’s Disease. [book auth.] Lester Packer, et al., et al. Micronutrients and Brain Health. Boca Raton: CRC Press: Taylor and Francis Group, LLC, 2010, 10, pp. 134-148. ISBN: 978-1-4200-7351-5.
  55. Bailey, Sarah J. and McCaffery, Peter J. Vulnerability of the Brain to Neuropsychiatric Disorders. [ed.] Michael S. Ritsner. Brain Protection in Schizophrenia, Mood and Cognitive Disorders. Dordrecht: Springer Science+Business Media B.V., 2010, 5, pp. 105-134. ISBN: 978-90-481-8552-8.
  56. Alzheimer's Scary Link To Diabetes. Rovner, Sophie L. 20, s.l.: American Chemical Society, May 18, 2009, Chemical & Engineering News, Vol. 87, pp. 42-46. ISSN: 0009-2347.
  57. Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimer's Disease. de la Monte, Suzanne M. [ed.] Debomoy K. Lahiri. 1, Indianapolis: Bentham Science Publishers, January 2012, Current Alzheimer Research, Vol. 9, pp. 35-66. DOI: 10.2174/156720512799015037; http://www.eurekaselect.com/88685/article. ISSN: 1567-2050.
  58. Tortora, Gerard J. and Derrickson, Bryan. The Cellular Level of Organization. Principles of Anatomy & Physiology. Hoboken: John Wiley & Sons, Inc., 2012, 3, pp. 63-112. ISBN: 13 978-0470-56510-0.
  59. Immune blood biomarkers of Alzheimer disease patients. Avagyan, Hripsime, et al., et al. [ed.] Cedric S. Raine. 1-2, Bronx: Elsevier Inc., May 29, 2009, Journal of Neuroimmunology, Vol. 210, pp. 67-72. DOI: 10.1016/j.jneuroim.2009.02.015; http://www.jni-journal.com/article/S0165-5728(09)00067-8/abstract. ISSN: 0165-5728.
  60. Freye, Enno. Principles in Nitrosative Stress. Acquired Mitochondropathy - A New Paradigm in Western Medicine Explaining Chronic Diseases. Dordrecht: Springer Science+Business Media, 2012, 6, pp. 55-70. ISBN: 978-94-007-2035-0.
  61. Fuglestad, Anita J., Ramel, Sara E. and Georgieff, Michael K. Micronutrient Needs of the Developing Brain: Priorities and Assessment. [ed.] Lester Packer, et al., et al. Micronutrients and Brain Health. Boca Raton: CRC Press: Taylor and Francis Group, LLC, 2010, 8, pp. 93-116. ISBN: 978-1-4200-7351-5.
  62. Effect of antioxidants (vitamin C, E and turmeric extract) on methimazole induced hypothyroidism in rats. Deshpande, U.R., Joseph, L.J., Patwardhan, U.N., Samuel, A.M. [ed.] K.S. Krishnan Marg. 6, New Delhi: National Institute of Science Communication and Information Resources, June 2002, Indian Journal of Experimental Biology, Vol. 40, pp. 735-738. ISSN: 0019-5189.
  63. Curcuminoids enhance memory in an amyloid-infused rat model of Alzheimer's disease. Ahmed, T., Enam, S.A., Gilani, A.H. [ed.] Stephen G. Lisberger. 3, Durham: Elsevier Ltd., September 1, 2010, Neuroscience, Vol. 169, pp. 1296-1306. DOI: 10.1016/j.neuroscience.2010.05.078; http://www.sciencedirect.com/science/article/pii/S0306452210008183. ISSN: 0306-4522.
  64. Alzheimer's disease, amnestic mild cognitive impairment, and age-associated memory impairment: current understanding and progress toward integrative prevention. Kidd, Parris M. [ed.] Kathleen A. Head. 2, Napa: Thorne Research, Inc., June 1, 2008, Alternative Medicine Review, Vol. 13. ISSN: 1089-5159.
  65. Duke, James A., Bogenschutz-Godwin, Mary Jo and duCellier, Judi. CRC Handbook of Medicinal Spices. Boca Raton: CRC Press LLC, 2003. ISBN: 0-8493-1279-5.
  66. Druggability of lead compounds from turmeric (Curcuma longa). Wilson, M., Balaji, S. and Eapen, S.J. 2006, Journal of Medicinal and Aromatic Plant Sciences, Vol. 28, pp. 384-390. ISSN: 0253-7125.
  67. Howes, Melanie-Jayne R. and Houghton, Peter J. Traditional Medicine for Memory Enhancement. [ed.] K.G. Ramawat. Herbal Drugs: Ethnomedicine to Modern Medicine. Berlin Heidelberg: Springer-Verlag, 2009, 15, pp. 239-292. ISBN: 978-3-540-79115-7.
  68. Foods for the prevention of diabetes: how do they work? Thomas, Theodoros and Pfeiffer, Andreas F.H. [ed.] Jesse Roth. 1, Manhasset: John Wiley & Sons, Ltd., January 3, 2012, Diabetes Metabolism Research and Reviews, Vol. 28, pp. 25-49. DOI: 10.1002/dmrr.1229; http://onlinelibrary.wiley.com/doi/10.1002/dmrr.1229/abstract. ISSN: 1520-7552.
  69. Marshall, Robert J. The Overlooked Role of Chronic Infection in Neurodegeneration and Its Reversal Using Nutraceutical Agents. Winter Park: Heise Health Clinic, 2005. pp. 1-23.
  70. Pressman, Alan H. and Buff, Sheila. The Complete Idiot's Guide to Vitamins and Minerals. New York: Alpha Books - Macmillan, Inc., 1997. ISBN: 0-02-862116-6.
  71. Strategies for Reducing or Preventing the Generation of Oxidative Stress. Poljsak, B. [ed.] Antonio Ayala. Article ID 194586, Sevilla: Hindawi Publishing Corporation, December 10, 2011, Oxidative Medicine and Cellular Longevity, Vol. 2011, pp. 1-15. DOI: 10.1155/2011/194586; http://www.hindawi.com/journals/omcl/2011/194586/. ISSN: 1942-0900.
  72. Molecular Targets of Dietary Polyphenols with Anti-inflammatory Properties. Yoon, Joo-Heon and Baek, Seung Joon. [ed.] Kwan Chul Tark. 5, Seoul: Yonsei University College of Medicine, October 31, 2005, Yonsei Medical Journal, Vol. 46, pp. 585-596. DOI: 10.3349/ymj.2005.46.5.585; http://synapse.koreamed.org/DOIx.php?id=10.3349/ymj.2005.46.5.585. ISSN: 0513-5796.
  73. Structural conversion of neurotoxic amyloid-β(1-42) oligomers to fibrils. Ahmed, Mahiuddin, et al., et al. [ed.] Boyana Konforti. 5, New York: Nature Publishing Group, May 2010, Nature Structural & Molecular Biology, Vol. 17, pp. 561-567. DOI: 10.1038/nsmb.1799; http://www.nature.com/nsmb/journal/v17/n5/full/nsmb.1799.html. ISSN: 1545-9993.
  74. Phenolic Compounds Prevent Alzheimer's Pathology through Different Effects on the Amyloid-β Aggregation Pathway. Hamaguchi, Tsuyoshi, F., et al., et al. [ed.] Michael P. Lisanti. 6, Philadelphia: American Society for Investigative Pathology, December 2009, The American Journal of Pathology, Vol. 175, pp. 2557-2565. DOI: 10.2353/ajpath.2009.090417; http://ajp.amjpathol.org/article/S0002-9440(10)60763-8/abstract. ISSN: 0002-9440.
  75. Impact of Dietary Polyphenols on Carbohydrate Metabolism. Hanhineva, Kati, et al., et al. [ed.] Andrei Alexandrescu. 4, Basel: MDPI AG, March 31, 2010, International Journal of Molecular Sciences, Vol. 11, pp. 1365-1402. DOI: 10.3390/ijms11041365; http://www.mdpi.com/1422-0067/11/4/1365. ISSN: 1422-0067.
  76. Jain, Kewal K. Neuroprotective Agents. The Handbook of Neuroprotection. Basel: Springer Science+Business Media, LLC, 2011, 2. ISBN: 978-1-161779-048-5.
  77. Alzheimer's Disease: The Pros and Cons of Pharmaceutical, Nutritional, Botanical, and Stimulatory Therapies, with a Discussion of Treatment Strategies from the Perspective of Patients and Practitioners. Wollen, Keith A. [ed.] Kathleen A. Head. 3, Napa: Thorne Research, Inc., September 2010, Alternative Medicine Review, Vol. 15, pp. 223-244. ISSN: 1089-5159.
  78. Amelioration of Obesity, Glucose Intolerance, and Oxidative Stress in High-Fat Diet and Low-Dose Streptozotocin-Induced Diabetic Rats by Combination Consisting of "Curcumin with Piperine and Quercetin". Kaur, Ginpreet and Chintamaneni, Meena. [ed.] T. Kumai and M.A. Prendergast. Article ID 957283, Mumbai: Hindawi Publishing Corporation, March 8, 2012, ISRN Pharmacology, Vol. 2012, pp. 1-7. DOI: 10.5402/2012/957283; http://www.hindawi.com/journals/isrn/2012/957283/. ISSN: 2090-5165.
  79. Effect of Polyphenols on Oxidative Stress and Mitochondrial Dysfunction in Neuronal Death and Brain Edema in Cerebral Ischemia. Panickar, Kiran S. and Anderson, Richard A. [ed.] Andrei Alexandrescu. 11, Basel: MDPI AG, November 18, 2011, International Journal of Molecular Sciences, Vol. 12, pp. 8181-8207. DOI: 10.3390/ijms12118181; http://www.mdpi.com/1422-0067/12/11/8181. ISSN: 1422-0067.
  80. The search for compounds that stimulate thermogenesis in obesity management: from pharmaceuticals to functional food ingredients. Dulloo, A.G., et al., et al. [ed.] David A. York. 10, Detroit: International Association for the Study of Obesity, October 2011, Obesity Reviews, Vol. 12, pp. 866-883. DOI: 10.1111/j.1467-789X.2011.00909.x; http://onlinelibrary.wiley.com/doi/10.1111/j.1467-789X.2011.00909.x/abstract. eISSN: 1467-789X.
  81. Optimized Turmeric Extracts have Potent Anti-Amyloidogenic Effects. Shytle, R. Douglas, et al., et al. [ed.] Debomoy K. Lahiri. 6, Indianapolis: Bentham Science Publishers, December 2009, Current Alzheimer Research, Vol. 6, pp. 564-571. DOI: 10.2174/156720509790147115; http://www.eurekaselect.com/85201/article. ISSN: 1567-2050.
  82. Cheng, Zhihong, Yu, Liangping and Yin, JunJie. Application of ESR in Wheat Antioidant Determination. [ed.] Liangli Yu. Wheat Antioxidants. Hoboken: Wiley-Interscience: John Wiley & Sons, Inc., 2008, 10, pp. 173-189. ISBN: 978-0-470-04259-5.
  83. Antioxidant and antiinflammatory activities of xanthorrhizol in hippocampal neurons and primary cultured microglia. Lim, Chol Seung, et al., et al. [ed.] Jean de Vellis. 6, Los Angeles: Wiley-Liss, Inc., December 15, 2005, Journal of Neuroscience Research, Vol. 82, pp. 831-838. DOI: 10.1002/jnr.20692; http://onlinelibrary.wiley.com/doi/10.1002/jnr.20692/abstract. ISSN: 0360-4012.
  84. Antiglycating potential of Zingiber officinalis and delay of diabetic cataract in rats. Saraswat, Megha, et al., et al. [ed.] Jeffrey Boatright. a165, Atlanta: Emory University, August 10, 2010, Molecular Vision, Vol. 16, pp. 1525-1537. ISSN: 1090-0535.
  85. Grape seed polyphenols and curcumin reduce genomic instability events in a transgenic mouse model for Alzheimer's disease. Thomas, Philip, et al., et al. [ed.] P.J. Stambrook, L.H.F. Mullenders and L.R. Ferguson. 1-2, Cincinnati; Leiden; Auckland: Elsevier B.V., February 10, 2009, Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, Vol. 661, pp. 25-34. DOI: 10.1016/j.mrfmmm.2008.10.016; http://www.sciencedirect.com/science/article/pii/S0027510708002571. ISSN: 0027-5107.
  86. Hounsome, N. and Hounsome, B. Biochemistry of Vegetables: Major Classes of Primary (Carbohydrates, Amino Acids, Fatty Acids, Vitamins, and Organic Acids) and Secondary Metabolites (Terpenoids, Phenolics, Alkaloids, and Sulfur-Containing Compounds) in Vegetables. [ed.] Nirmal K. Sinha, et al., et al. Handbook of Vegetables and Vegetable Processing. Danvers: Wiley-Blackwell: Blackwell Publishing Ltd., 2011, 2, pp. 23-58. ISBN: 978-0-8138-1541-1.
  87. Mok, Su San and Bush, Ashley I. Therapeutics of Alzheimer’s Disease Based on Metal Bioavailability. [ed.] Lester Packer, et al., et al. Micronutrients and Brain Health. Boca Raton: CRC Press: Taylor and Francis Group, LLC, 2010, 9, pp. 117-132. ISBN: 978-1-4200-7351-5.
  88. Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer's disease animal models. Baum, Larry and Ng, Alex. [ed.] Mark A. Smith. 4, Cleveland: IOS Press, August 31, 2004, Journal of Alzheimer's Disease, Vol. 6, pp. 367-377. ISSN: 1387-2877.
  89. Aggarwal, Bharat B., et al., et al. Curcumin: The Indian Solid Gold. [ed.] Bharat B. Aggarwal, Young-Joon Surh and Shishir Shishodia. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease. New York: Springer Science+Business Media, LLC, 2007, pp. 1-76. ISBN-13:978-0-387-46400-8.
  90. PPARγ and Agonists against Cancer: Rational Design of Complementation Treatments. Veliceasa, Dorina, Schulze-Hoëpfner, Frank Thilo and Volpert, Olga V. [ed.] Dipak Panigrahy. Article ID 945275, Boston: Hindawi Publishing Corporation, November 18, 2008, PPAR Research, Vol. 2008, pp. 1-13. DOI: 10.1155/2008/945275; http://www.hindawi.com/journals/ppar/2008/945275/. ISSN: 1687-4757.
  91. Amyloid Oligomers Induce Phosphorylation of Tau and Inactivation of Insulin Receptor Substrate via c-Jun N-Terminal Kinase Signaling: Suppression by Omega-3 Fatty Acids and Curcumin. Ma, Qiu-Lan, et al., et al. [ed.] John Maunsell. 28, Chicago: Society for Neuroscience, July 15, 2009, The Journal of Neuroscience, Vol. 29, pp. 9078-9089. DOI: 10.1523/JNEUROSCI.1071-09.2009; http://www.jneurosci.org/content/29/28/9078. ISSN: 0270-6474.
  92. Champeau, Rachel. Vitamin D, curcumin may help clear amyloid plaques found in Alzheimer’s. University of California. [Online] July 15, 2009. [Cited: March 4, 2015.] http://newsroom.ucla.edu/portal/ucla/ucla-study-finds-vitamin-d-may-94903.aspx.
  93. Oral Curcumin for the Treatment of Mild-to-Moderate Alzheimer’s Disease: Tolerability and Clinical and Biomarker Efficacy Results of a Placebo-Controlled 24-week Study. Ringman, John M., et al., et al. Chicago: s.n., 2008. Proceedings of the Abstract of International Conference on Alzheimer’s Disease. p. T774. P4-344.
  94. Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model. Koronyo-Hamaoui, Maya, et al., et al. [ed.] Paul Fletcher. 1, Cambridge: Elsevier Inc., January 2011, NeuroImage, Vol. 54, pp. S204–S217. DOI: 10.1016/j.neuroimage.2010.06.020; http://www.sciencedirect.com/science/article/pii/S1053811910008645. ISSN: 1053-8119.
  95. Curcumin and Alzheimer's Disease. Hamaguchi, Tsuyoshi, Ono, Kenjiro and Yamada, Masahito. [ed.] Ding-Feng Su. 5, Shanghai: Blackwell Publishing Ltd, October 2010, CNS Neuroscience & Therapeutics, Vol. 16, pp. 285-297. DOI: 10.1111/j.1755-5949.2010.00147.x; http://onlinelibrary.wiley.com/doi/10.1111/j.1755-5949.2010.00147.x/abstract. eISSN: 1755-5949.
  96. Six-Month Randomized, Placebo-Controlled, Double-Blind, Pilot Clinical Trial of Curcumin in Patients With Alzheimer Disease. Baum, Larry, et al., et al. [ed.] Richard I. Shader and David J. Greenblatt. 1, Medford: Lippincott Williams & Wilkins, Inc., February 2008, Journal of Clinical Psychopharmacology, Vol. 28, pp. 110-113. DOI: 10.1097/jcp.0b013e318160862c; http://journals.lww.com/psychopharmacology/Citation/2008/02000/Six_Month_Randomized,_Placebo_Controlled,.25.aspx. ISSN: 0271-0749.
  97. Schor, Jacob. Alzheimer’s Disease and Curcumin: a Protocol Update. Denver Naturopathic Clinic. [Online] June 15, 2010. [Cited: July 31, 2015.] http://www.denvernaturopathic.com/Alzheimers2010update.htm.
  98. Injectable Sustained Release Microparticles of Curcumin: A New Concept for Cancer Chemoprevention. Shahani, Komal, et al., et al. [ed.] George C. Prendergast. 11, Wynnewood: American Association for Cancer Research, June 1, 2010, Cancer Research, Vol. 70, pp. 4443-4452. DOI: 10.1158/0008-5472.CAN-09-4362; http://cancerres.aacrjournals.org/content/70/11/4443. ISSN: 0008-5472.
  99. Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier. Makadia, Hirenkumar K. and Siegel, Steven J. [ed.] Alexander Böker. 3, Potsdam: MDPI AG, August 8, 2011, Polymers, Vol. 3, pp. 1377-1397. DOI: 10.3390/polym3031377; http://www.mdpi.com/2073-4360/3/3/1377. eISSN: 2073-4360.
  100. The Michael J. Fox Foundation for Parkinson’s Research. Understanding Parkinson's. The Michael J. Fox Foundation for Parkinson's Research. [Online] [Cited: March 5, 2015.] https://www.michaeljfox.org/understanding-parkinsons/index.html.
  101. Freye, Enno. Nitrosative Stress in Diverse Multisystem Diseases. Acquired Mitochondropathy - A New Paradigm in Western Medicine Explaining Chronic Diseases. Dordrecht: Springer Science+Business Media, 2012, 7, pp. 71-216. ISBN: 978-94-007-2035-0.
  102. Tortora, Gerard J. and Derrickson, Bryan. Nervous Tissue. Principles of Anatomy & Physiology. Hoboken: John Wiley & Sons, Inc., 2012, 12, pp. 447-491. ISBN: 13 978-0470-56510-0.
  103. Mitochondrial Fusion/Fission, Transport and Autophagy in Parkinson's Disease: When Mitochondria Get Nasty. Arduíno, Daniela M., Esteves, A. Raquel and Cardoso, Sandra M. [ed.] Charleen T. Chu. Article ID 767230, Pittsburgh: Hindawi Publishing Corporation, February 20, 2011, Parkinson's Disease, Vol. 2011, pp. 1-13. DOI: 10.4061/2011/767230; http://www.hindawi.com/journals/pd/2011/767230/. ISSN: 2090-8083.
  104. University of British Columbia. Severe Flu Increases Risk of Parkinson's. ScienceDaily. [Online] July 20, 2012. [Cited: March 5, 2015.] http://www.sciencedaily.com/releases/2012/07/120720135717.htm.
  105. Curcumin inhibits influenza virus infection and haemagglutination activity. Chen, Da-Yuan, et al., et al. [ed.] G.G. Birch. 4, Reading: Elsevier B.V., April 15, 2010, Food Chemistry, Vol. 119, pp. 1346-1351. DOI: 10.1016/j.foodchem.2009.09.011; http://www.sciencedirect.com/science/article/pii/S0308814609010553. ISSN: 0308-8146.
  106. Curcuminoids from Curcuma longa and their inhibitory activities on influenza A neuraminidases. Dao, Trong Tuan, et al., et al. [ed.] G.G. Birch. 1, Reading: Elsevier Ltd., September 1, 2012, Food Chemistry, Vol. 134, pp. 21-28. DOI: 10.1016/j.foodchem.2012.02.015; http://www.sciencedirect.com/science/article/pii/S030881461200180X. ISSN: 0308-8146.
  107. The Medicinal Potential of Influenza Virus Surface Proteins: Hemagglutinin and Neuraminidase. Xie, Y., et al., et al. [ed.] Atta-ur-Rahman. 7, Karachi: Bentham Science Publishers, March 1, 2011, Current Medicinal Chemistry, Vol. 18. DOI: 10.2174/092986711794940815; http://www.eurekaselect.com/73473/article. ISSN: 1875-533X.
  108. Inhibition of monoamine oxidase-B by the polyphenolic compound, curcumin and its metabolite tetrahydrocurcumin, in a model of Parkinson's disease induced by MPTP neurodegeneration in mice. Rajeswari, A. and Sabesan, M. [ed.] K.D. Rainsford. 2, Sheffield: SP Birkhäuser Verlag Basel, April 1, 2008, Inflammopharmacology, Vol. 16, pp. 96-99. DOI: 10.1007/s10787-007-1614-0; http://link.springer.com/article/10.1007%2Fs10787-007-1614-0. ISSN: 0925-4692.
  109. Buchbauer, Gerhard. Biological Activities of Essential Oils. [ed.] K. Hüsnü Can Baṣer and Gerhard Buchbauer. Handbook of Essential Oils: Science, Technology, and Applications. Boca Raton: CRC Press: Taylor and Francis Group, LLC, 2010, 9, pp. 235-280. ISBN: 978-1-4200-6315-8.
  110. Heuberger, Eva. Central Nervous System Effects of Essential Oils in Humans. [ed.] K. Hüsnü Can Baṣer and Gerhard Buchbauer. Handbook of Essential Oils: Science, Technology, and Applications. Boca Raton: CRC Press: Taylor and Francis Group, LLC, 2010, 10.1, pp. 281-296. ISBN: 978-1-4200-6315-8.
  111. Gerstein, Paul S. Delirium, Dementia, and Amnesia in Emergency Medicine. Medscape Reference: Drugs, Diseases & Procedures. [Online] April 4, 2013. [Cited: March 5, 2015.] http://emedicine.medscape.com/article/793247-overview#showall.
  112. Davis, Charles Patrick. Encephalopathy: What is encephalopathy?; What causes encephalopathy? MedicineNet. [Online] June 9, 2014. [Cited: March 5, 2015.] http://www.medicinenet.com/encephalopathy/article.htme.
  113. Dementia syndromes: evaluation and treatment. Scott, Kevin R. and Barrett, Anna M. [ed.] Laura McGovern. 4, London: Informa Plc, April 2007, Expert Review of Neurotherapeutics, Vol. 7, pp. 407-422. DOI: 10.1586/14737175.7.4.407; http://informahealthcare.com/doi/abs/10.1586/14737175.7.4.407. ISSN: 1473-7175.
  114. Marcovitch, Harvey. Black's Medical Dictionary. 41. London: A & C Black Publishers Limited, 2005. ISBN: 0-7136-6146-1.
  115. Fuller, Gregory N., Goodman, J. Clay and Bouldin, Thomas W. The Nervous System. [ed.] Raphael Rubin, David S. Strayer and Emanuel Rubin. Rubin's Pathology: Clinicopathologic Foundations of Medicine. 6. Philadelphia: Wolters Kluwer: Lippincott Williams & Wilkins, 2012, 28, pp. 1295-1392. ISBN: 978-1-60547-968-2.
  116. Fry, Mitchell. Nerve and muscle systems. Essential Biochemistry for Medicine. Chichester: Wiley-Blackwell: John Wiley & Sons Ltd., 2010, 17, pp. 237-254. ISBN: 978-0-470-74328-7.
  117. Newsholme, Eric A. and Leech, Tony R. Defence Against Pathogens: Barriers, Enzymes and the Immune System. Functional Biochemistry in Health and Disease. Chichester: Wiley-Blackwell: John Wiley & Sons, Ltd, 2010, 17, pp. 375-416. ISBN: 978-0-471-98820-5.
  118. Bovine spongiform encephalopathy and Creutzfeldt-Jacob's disease - 15 years later, where do we stand? Chatzidaki, E.E. [ed.] John Meletis. 3, Athens: Athens Medical Society, June 2010, Archives of Hellenic Medicine, Vol. 27, pp. 471-474. ISSN: 1105-3992.
  119. Hepatic encephalopathy: An approach to its multiple pathophysiological features. Perazzo, Juan Carlos, et al., et al. [ed.] Masatoshi Kudo. 3, Osaka: Baishideng Publishing Group Co., Limited, March 27, 2012, World Journal of Hepatology, Vol. 4, pp. 50-65. DOI: 10.4254/wjh.v4.i3.50; http://www.wjgnet.com/1948-5182/full/v4/i3/50.htm. ISSN: 1948-5182.
  120. Prasad, Sahdeo and Aggarwal, Bharat B. Turmeric, the Golden Spice: From Traditional Medicine to Modern Medicine. [ed.] Iris F.F. Benzie and Sissi Wachtel-Galor. Herbal Medicine: Biomolecular and Clinical Aspects. 2. Boca Raton: CRC Press: Taylor and Francis Group, LLC, 2011, 13, pp. 263-288. ISBN: 978-1-4398-0713-2.
  121. Kumar, Addanki P., et al., et al. An Overview of Anticancer Herbal Medicines. [ed.] William C.S. Cho. Evidence-Based Anticancer Materia Medica. Dordrecht: Springer Science+Business Media B.V., 2011, 1, pp. 1-36. ISBN: 978-94-007-0525-8.
  122. NINDS Office of Communications and Public Liaison. Acute Disseminated Encephalomyelitis Information Page. National Institute of Neurological Disorders and Stroke. [Online] February 14, 2014. [Cited: March 5, 2015.] http://www.ninds.nih.gov/disorders/acute_encephalomyelitis/acute_encephalomyelitis.htm.
  123. The Cleveland Clinic Foundation. Diseases & Conditions: Acute Disseminated Encephalomyelitis (ADEM). The Cleveland Clinic. [Online] August 22, 2014. [Cited: March 5, 2015.] http://my.clevelandclinic.org/disorders/acute_disseminated_encephalomyelitis_adem/hic_overview.aspx.
  124. Antidepressant activity of curcumin: involvement of serotonin and dopamine system. Kulkarni, Shrinivas K., Bhutani, Mohit Kumar and Bishnoi, Mahendra. [ed.] T.W. Robbins, et al., et al. 3, Cambridge; Medford; London; Melbourne; Chicago; London; Providence; Beerse; Philadelphia; Chapel Hill: Springer-Verlag, December 1, 2008, Psychopharmacology , Vol. 201, pp. 435-442. DOI: 10.1007/s00213-008-1300-y; http://link.springer.com/article/10.1007%2Fs00213-008-1300-y. ISSN: 0033-3158.
  125. Milbury, Paul E. Transport of Flavonoids into the Brain. [ed.] Lester Packer, et al., et al. Micronutrients and Brain Health. Boca Raton: CRC Press: Taylor and Francis Group, LLC, 2010, 19, pp. 265-280. ISBN: 978-1-4200-7351-5.
  126. Nunes, Domingos Sávio, et al., et al. Effects of Essential Oils in the Central Nervous System: Psychopharmacology of Essential Oils. [ed.] K. Hüsnü Can Baṣer and Gerhard Buchbauer. Handbook of Essential Oils: Science, Technology, and Applications. Boca Raton: CRC Press: Taylor and Francis Group, LLC, 2010, 10.2, pp. 297-306. ISBN: 978-1-4200-6315-8.
  127. Lis-Balchin, Maria. Aromatherapy with Essential Oils. [ed.] K. Hüsnü Can Baṣer and Gerhard Buchbauer. Handbook of Essential Oils: Science, Technology, and Applications. Boca Raton: CRC Press: Taylor and Francis Group, LLC, 2010, 11, pp. 549-584. ISBN: 978-1-4200-6315-8.
  128. Krzyzanowska, Justyna, Czubacka, Anna and Oleszek, Wieslaw. Dietary Phytochemicals and Human Health. [ed.] Maria Teresa Giardi, Giuseppina Rea and Bruno Berra. Bio-Farms for Nutraceuticals: Functional Food and Safety Control by Biosensors. Austin: Landes Bioscience and Springer Science+Business Media, LLC, 2010, 7, pp. 74-98. ISBN: 978-1-4419-7346-7.
  129. The Role of Dietary Polyphenols on Adult Hippocampal Neurogenesis: Molecular Mechanisms and Behavioural Effects on Depression and Anxiety. Dias, Gisele Pereira, et al., et al. Article ID 541971, Modena: Hindawi Publishing Corporation, April 17, 2012, Oxidative Medicine and Cellular Longevity, Vol. 2012, pp. 1-18. DOI: 10.1155/2012/541971; http://www.hindawi.com/journals/omcl/2012/541971/. ISSN: 1942-0900.
  130. Bouayed, Jaouad. Relationship Between Oxidative Stress and Anxiety: Emerging Role of Antioxidants Within Therapeutic or Preventive Approaches. [ed.] Vladimir V. Kalinin. Anxiety Disorders. Rijeka: InTech, 2011, 2, pp. 27-38. ISBN: 978-953-307-592-1.
  131. The molecular basis of neurodegeneration in multiple sclerosis. Lassmann, Hans and van Horssen, Jack. [ed.] Felix Wieland. 23, Heidelberg: Elsevier B.V., December 1, 2011, FEBS Letters, Vol. 585, pp. 3715-3723. DOI: 10.1016/j.febslet.2011.08.004; http://www.febsletters.org/article/S0014-5793(11)00593-X/abstract. ISSN: 0014-5793.
  132. Shah, Jyoti. Herbal Treatments for Erectile Dysfunction. [ed.] K.G. Ramawat. Herbal Drugs: Ethnomedicine to Modern Medicine. Berlin Heidelberg: Springer-Verlag, 2009, 5, pp. 67-80. ISBN: 978-3-540-79115-7.
  133. May Diet and Dietary Supplements Improve the Wellness of Multiple Sclerosis Patients? A Molecular Approach. Riccio, Paolo, Rossano, Rocco and Liuzzi, GraziaMaria. [ed.] Corrado Betterle. Article ID 249842, Padua: SAGE-Hindawi Access to Research, December 27, 2010, Autoimmune Diseases, Vol. 2010, pp. 1-12. DOI: 10.4061/2010/249842; http://www.hindawi.com/journals/ad/2010/249842/. ISSN: 2090-0430.
  134. Bright, John J. Curcumin and Autoimmune Disease. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease. New York: Aggarwal, Bharat B.; Surh, Young-Joon; Shishodia, Shishir, 2007, pp. 425-452. ISBN-13:978-0-387-46400-8.
  135. Curcumin has bright prospects for the treatment of multiplesclerosis. Xiea, Lin, Li, Xiao-Kang and Takahara, Shiro. [ed.] J.E. Talmadge. 3, Omaha: Elsevier B.V., March 2011, International Immunopharmacology, Vol. 11, pp. 323-330. DOI: 10.1016/j.intimp.2010.08.013; http://www.sciencedirect.com/science/article/pii/S1567576910002675. ISSN: 1567-5769.
  136. Oral flavonoids delay recovery from experimental autoimmune encephalomyelitis in SJL mice. Verbeek, Richard, van Tol, Eric. A.F. and van Noort, Johannes M. [ed.] Sam J. Enna. 2, Kansas City: Elsevier B.V., July 15, 2005, Biochemical Pharmacology, Vol. 70, pp. 220-228. DOI: 10.1016/j.bcp.2005.04.041; http://www.sciencedirect.com/science/article/pii/S0006295205002340. ISSN: 0006-2952.
  137. Aggarwal, Bharat B., et al., et al. Curcumin Derived from Turmeric (Curcuma longa): a Spice for All Seasons. [ed.] Debasis Bagchi and Harry G. Preuss. Phytopharmaceuticals in Cancer Chemoprevention. Boca Raton: CRC Press LLC, 2005, 23, pp. 349-388. ISBN: 0-8493-1560-3.
  138. Immunomodulatory responses of peripheral blood mononuclear cells from multiple sclerosis patients upon in vitro incubation with the flavonoid luteolin: additive effects of IFN-β. Sternberg, Zohara, et al., et al. [ed.] Sue T. Griffin and Robert E. Mrak. 28, Little Rock; Toledo: BioMed Central Ltd., October 13, 2009, Journal of Neuroinflammation, Vol. 6. DOI: 10.1186/1742-2094-6-28; http://www.jneuroinflammation.com/content/6/1/28. eISSN: 1742-2094.
  139. Differential regulation of CD4+ T helper cell responses by curcumin in experimental autoimmune encephalomyelitis. Kanakasabai, Saravanan, et al., et al. [ed.] Edward A. Dennis and Joseph L. Witztum. 11, San Diego: American Society for Biochemistry and Molecular Biology, March 6, 2012, The Journal of Nutritional Biochemistry, Vol. 23, pp. 1498-1507. DOI: 10.1016/j.jnutbio.2011.10.002; http://www.jnutbio.com/article/S0955-2863(11)00288-9/abstract. ISSN: 0022-2275.
  140. Miriyala, Sumitra, Panchatcharam, Manikandan and Rengarajulu, Puvanakrishnan. Cardioprotective Effects of Curcumin. [ed.] Bharat B. Aggarwal, Young-Joon Surh and Shishir Shishodia. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease. New York: Springer Science+Business Media, LLC, 2007, pp. 359-378. ISBN-13:978-0-387-46400-8.
  141. Wilberger, James E. and Dupre, Derrick A. Intracranial Hematomas. Merck Sharp & Dohme Corp. [Online] November 2013. [Cited: March 6, 2015.] http://www.merckmanuals.com/home/injuries_and_poisoning/head_injuries/intracranial_hematomas.html.
  142. Curcumin (Diferuloylmethane) Induces Apoptosis and Blocks Migration of Human Medulloblastoma Cells. Bangaru, Madhavi Latha Yadav, et al., et al. [ed.] Gen-Ichiro Soma. 2, Takamatsu: The International Institute of Anticancer Research, February 2010, Anticancer Research, Vol. 30, pp. 499-504. ISSN: 0250-7005.
  143. Epigenetic changes induced by curcumin and other natural compounds. Reuter, Simone, et al., et al. [ed.] Giuditta Perozzi, et al., et al. 2, Rome; Lausanne; Utrecht: Springer-Verlag, May 1, 2011, Genes & Nutrition, Vol. 6, pp. 93-108. DOI: 10.1007/s12263-011-0222-1; http://link.springer.com/article/10.1007%2Fs12263-011-0222-1. ISSN: 1555-8932.
  144. Caldecott, Todd. Ayurveda: The Divine Science of Life. s.l.: Elsevier Health Sciences, 2006. ISBN: 978-0-7234-3410-8.
  145. Barnes, Joanne, Anderson, Linda A. and Phillipson, J. David. Herbal Medicines. 3. London: Pharmaceutical Press: RPS Publishing, 2007. ISBN: 978-0-85369-623-0.
  146. Committee on Herbal Medicinal Products. Assessment Report on Curcuma Longa L. Rhizoma. London: European Medicines Agency, 2009. EMEA/HMPC/456848/2008.
  147. Hsu, Chih-Hung and Cheng, Ann-Lii. Clinical Studies with Curcumin. [ed.] Bharat B. Aggarwal, Young-Joon Surh and Shishir Shishodia. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease. New York: Springer Science+Business Media, LLC, 2007, pp. 471-480. ISBN-13: 978-0-387-46400-8.
  148. High TNF-alpha plasma levels and macrophages iNOS and TNF-alpha expression as risk factors for painful diabetic neuropathy. Purwata, Thomas Eko. [ed.] Howard S. Smith. Albany: Dove Medical Press, June 29, 2011, Journal of Pain Research, Vol. 4, pp. 169-175. DOI: 10.2147/JPR.S21751; http://www.dovepress.com/high-tnf-alpha-plasma-levels-and-macrophages-inos-and-tnf-alpha-expres-peer-reviewed-article-JPR. ISSN: 1178-7090.
  149. Phase II Clinical Trial on Effect of the Long Turmeric (Curcuma Longa Linn) on Healing of Peptic Ulcer. Prucksunand, Chaweewan, et al., et al.  [ed.] Suvanee Supavej. 1, Bangkok: SEAMEO Regional Tropical Medicine and Public Health Network, March 2001, The Southeast Asian Journal of Tropical Medicine and Public Health, Vol. 32, pp. 208-215. ISSN: 0125-1562.
  150. Efficacy of turmeric (curcumin) in pain and postoperative fatigue after laparoscopic cholecystectomy: a double-blind, randomized placebo-controlled study. Agarwal, Krishna Adit, et al., et al. [ed.] Mark A. Talamini and Sir Alfred Cuschieri. 12, Stony Brook; Dundee: Springer-Verlag, December 1, 2011, Surgical Endoscopy, Vol. 25, pp. 3805-3810. DOI: 10.1007/s00464-011-1793-z; http://link.springer.com/article/10.1007%2Fs00464-011-1793-z. ISSN: 0930-2794.
  151. Early Human Safety Study of Turmeric Oil (Curcuma longa oil) administered orally in healthy volunteers. Joshi, Jayashree, et al., et al. [ed.] Shashank R. Joshi. Mumbai: Association of Physicians of India, November 2003, Journal of The Association of Physicians of India, Vol. 51, pp. 1055-1060. ISSN: 0004-5772.
  152. Evaluation of antihyperalgesic effect of curcumin on formalin-induced orofacial pain in rat. Mittal, Nitt, et al., et al. [ed.] Elizabeth M. Williamson, et al., et al. 4, Reading; Naples; Seoul; Charleston: John Wiley & Sons, Ltd., April 2009, Phytotherapy Research, Vol. 23, pp. 507-512. DOI: 10.1002/ptr.2662; http://onlinelibrary.wiley.com/doi/10.1002/ptr.2662/abstract. eISSN: 1099-1573.
  153. Gautam, Subhash C., Gao, Xiaohua and Dulchavsky, Scott. Immunomodulation by Curcumin. [ed.] Bharat B. Aggarwal, Young-Joon Surh and Shishir Shishodia. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease. New York: Springer Science+Business Media, LLC, 2007, pp. 321-342. ISBN-13:978-0-387-46400-8.
  154. Origins of Plant Derived Medicines. Maridass, M. and Britto, A. John De. 12, Palayamkottai: s.n., June 11, 2008, Ethnobotanical Leaflets, pp. 373-387. ISSN: 1948-3570.
  155. Molecular Targets of Nutraceuticals Derived from Dietary Spices: Potential Role in Suppression of Inflammation and Tumorigenesis. Aggarwal, Bharat B., et al., et al. [ed.] Steven R. Goodman. 8, Syracuse: SAGE: The Society for Experimental Biology and Medicine, August 2009, Experimental Biology and Medicine, Vol. 234, pp. 825-849. DOI: 10.3181/0902-MR-78; http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141288/. ISSN: 1535-3699.
  156. Harris, Bob. Phytotherapeutic Uses of Essential Oils. [ed.] K. Hüsnü Can Baṣer and Gerhard Buchbauer. Handbook of Essential Oils: Science, Technology, and Applications. Boca Raton: CRC Press: Taylor and Francis Group, LLC, 2010, 11, pp. 315-353. ISBN: 978-1-4200-6315-8.
  157. Germacrone inhibits the proliferation of breast cancer cell lines by inducing cell cycle arrest and promoting apoptosis. Zhong, Zhangfeng, et al., et al. [ed.] FP. Nijkamp. 1-3, Utrecht: Elsevier B.V., September 30, 2011, European Journal of Pharmacology, Vol. 667, pp. 50-55. DOI: 10.1016/j.ejphar.2011.03.041; http://www.sciencedirect.com/science/article/pii/S0014299911003578. ISSN: 0014-2999.
  158. Khan, Ikhlas A. and Abourashed, Ehab A. Leung's Encyclopedia of Common Natural Ingredients: Used in Food, Drugs and Cosmetics. 3. Hoboken: John Wiley & Sons, Inc., 2010. ISBN: 978-0-471-46743-4.
  159. Nunes, Domingos Sávio, et al., et al. Effects of Essential Oils in the Central Nervous System: Central Nervous System Effects of Essential Oils in Humans. [ed.] K. Hüsnü Can Baṣer and Gerhard Buchbauer. Handbook of Essential Oils: Science, Technology, and Applications. Boca Raton: CRC Press: Taylor and Francis Group, LLC, 2010, 10.1, pp. 281-296. ISBN: 978-1-4200-6315-8.
  160. A pilot study of the antioxidant effect of curcumin in tropical pancreatitis. Durgaprasad, S., et al., et al. [ed.] V.M. Katoch. 4, New Delhi: Indian Council of Medical Research, October 2005, Indian Journal of Medical Research, Vol. 122, pp. 315-318. ISSN: 0971-5916.
  161. Pharmacokinetic and pharmacodynamic interactions of valproate, phenytoin, phenobarbitone and carbamazepine with curcumin in experimental models of epilepsy in rats. Reeta, K.H., et al., et al. [ed.] George F. Koob. 3, La Jolla: Elsevier Inc., September 2011, Pharmacology Biochemistry and Behavior, Vol. 99, pp. 399-407. DOI: 10.1016/j.pbb.2011.05.011; http://www.sciencedirect.com/science/article/pii/S0091305711001535. ISSN: 0091-3057.
  162. Pictorial Review of Glutamate Excitotoxicity: Fundamental Concepts for Neuroimaging. Mark, Leighton P., et al., et al. [ed.] Robert M. Quencer. 3, Miami: American Society of Neuroradiology, Nov-Dec 2001, American Journal of Neuroradiology, Vol. 22, pp. 1813-1824. ISSN: 1936-959X.
  163. Biological Sciences Curriculum Study. The Brain: Understanding Neurobiology Through the Study of Addiction - Neurons, Brain Chemistry, and Neurotransmission. Colorado Springs: U.S. Department of Health and Human Services: National Institutes of Health, 2010. pp. 41-64. NIH Publication No. 09-4871 ISBN: 1-929614-05-5.
  164. Frontier of Epilepsy Research - mTOR signaling pathway. Dae-Myung Jue. 5, Seoul: Nature Publishing Group; Korean Society for Biochemistry and Molecular Biology , May 31, 2011, Experimental & Molecular Medicine, Vol. 43, pp. 231-274. DOI: 10.3858/emm.2011.43.5.032; http://www.nature.com/emm/journal/v43/n5/full/emm201128a.html. eISSN: 2092-6413.
  165. Shpakov, Alexander, et al., et al. Hormonal Signaling Systems of the Brain in Diabetes Mellitus. [ed.] Raymond Chuen-Chung Chang. Neurodegenerative Diseases - Processes, Prevention, Protection and Monitoring. s.l.: InTech, 2011, 15, pp. 349-386. ISBN: 978-953-307-485-6.
  166. Evaluation of the antiepileptic effect of curcumin and Nigella sativa oil in the pilocarpine model of epilepsy in comparison with valproate. Noor, Neveen A., et al., et al. [ed.] Steven C. Schachter. 2, Boston: Elsevier Inc., June 2012, Epilepsy & Behavior, Vol. 24, pp. 199-206. DOI: 10.1016/j.yebeh.2012.03.026; http://www.epilepsybehavior.com/article/S1525-5050(12)00171-0/abstract. ISSN: 1525-5050.
  167. Evaluation of the antiepileptic effect of curcumin and Nigella sativa oil in the pilocarpine model of epilepsy in comparison with valproate. Noor, Neveen A., et al., et al. [ed.] Steven C. Schachter. 2, Boston: Elsevier Inc., June 2012, Epilepsy & Behavior, Vol. 24, pp. 199-206. DOI: 10.1016/j.yebeh.2012.03.026; http://www.epilepsybehavior.com/article/S1525-5050(12)00171-0/abstract. ISSN: 1525-5050.
  168. Natural Antioxidants May Prevent Posttraumatic Epilepsy: A Proposal Based on Experimental Animal Studies. Mori, Akitane, et al., et al. [ed.] Masao Yamada. 3, Okayama: Okayama University Medical School, June 2004, Acta Medica Okayama, Vol. 58, pp. 111-118. ISSN: 0386-300X.
  169. Protective effect of curcumin against seizures and cognitive impairment in a pentylenetetrazole-kindled epileptic rat model. Mehla, Jogender, et al., et al. [ed.] Frank Porreca. 19-22, Tucson: Elsevier Inc., November 20, 2010, Life Sciences, Vol. 87, pp. 596-603. DOI: 10.1016/j.lfs.2010.09.006; http://www.sciencedirect.com/science/article/pii/S0024320510003814. ISSN: 0024-3205.
  170. Dietary Curcumin Attenuates Glioma Growth in a Syngeneic Mouse Model by Inhibition of the JAK1,2/STAT3 Signaling Pathway. Weissenberger, Jakob, et al., et al. [ed.] Kenneth C. Anderson. 23, Philadelphia: American Association for Cancer Research, December 1, 2010, Clinical Cancer Research, Vol. 16, pp. 5781-5795. DOI: 10.1158/1078-0432.CCR-10-0446; http://clincancerres.aacrjournals.org/content/16/23/5781. ISSN: 1557-3265.
  171. Essential Oils and Their Constituents: Anticonvulsant Activity. de Almeida, Reinaldo Nóbrega, et al., et al. [ed.] Derek J. McPhee. 3, Emeryville: MDPI AG, March 23, 2011, Molecules, Vol. 16, pp. 2726-2742. DOI: 10.3390/molecules16032726; http://www.mdpi.com/1420-3049/16/3/2726. ISSN: 1420-3049.
  172. Anticonvulsant activity of bisabolene sesquiterpenoids of Curcuma longa in zebrafish and mouse seizure models. Orellana-Paucar, Adriana Monserrath, et al., et al. [ed.] Steven C. Schachter. 1, Boston: Elsevier Inc., May 2012, Epilepsy & Behavior, Vol. 24, pp. 14-22. DOI: 10.1016/j.yebeh.2012.02.020; http://www.epilepsybehavior.com/article/S1525-5050(12)00086-8/abstract. ISSN: 1525-5050.
  173. GABA receptor agonists: pharmacological spectrum and therapeutic actions. Bartholini, G. 1, s.l.: Wiley Periodicals, Inc., January/March 1985, Medicinal Research Reviews, Vol. 5, pp. 55-75. DOI: 10.1002/med.2610050103; http://onlinelibrary.wiley.com/doi/10.1002/med.2610050103/abstract. eISSN: 1098-1128.
  174. Effect of eugenol on spreading depression and epileptiform discharges in rat neocortical and hippocampal tissues. orm discharges in rat neocortical and hippocampal tissues. Müller, M., et al., et al. [ed.] Stephen G. Lisberger. 2, Durham: Elsevier Ltd., June 30, 2006, Neuroscience, Vol. 140, pp. 743-751. DOI: 10.1016/j.neuroscience.2006.02.036; http://www.sciencedirect.com/science/article/pii/S0306452206002399. ISSN: 0306-4522.
  175. Curcumin as an Add-On to Antidepressive Treatment: A Randomized, Double-Blind, Placebo-Controlled, Pilot Clinical Study. Bergman, Joseph, et al., et al. [ed.] Peter A. LeWitt. 3, West Bloomfield: Wolters Kluwer Health, Inc., May/June 2013, Clinical Neuropharmacology, Vol. 36, pp. 73-77. DOI: 10.1097/WNF.0b013e31828ef969; http://journals.lww.com/clinicalneuropharm/pages/articleviewer.aspx?year=2013&issue=05000&article=00001&type=abstract. ISSN: 0362-5664.
  176. Efficacy and Safety of Curcumin in Major Depressive Disorder: A Randomized Controlled Trial. Sanmukhani, Jayesh, et al., et al. [ed.] Elizabeth M. Williamson, et al., et al. 4, Reading; Naples; Seoul; Charleston: John Wiley & Sons, Ltd., April 2014, Phytotherapy Research, Vol. 28, pp. 579-585. DOI: 10.1002/ptr.5025; http://onlinelibrary.wiley.com/doi/10.1002/ptr.5025/abstract. eISSN: 1099-1573.
  177. Curcumin for the treatment of major depression: A randomised, double-blind, placebo controlled study. Lopresti, Adrian L., et al., et al. [ed.] Cornelius Katona and Hagop Akiskal. London; San Diego: Elsevier Inc., October 1, 2014, Journal of Affective Disorders, Vol. 167, pp. 368-375. DOI: 10.1016/j.jad.2014.06.001; http://www.jad-journal.com/article/S0165-0327(14)00362-0/abstract. ISSN: 0165-0327.
  178. Clinical Drug Information, LLC. Escitalopram. Drugs.com. [Online] April 1, 2015. [Cited: April 8, 2015.] .
  179. Cerner Multum, Inc. Venlafaxine. Drugs.com. [Online] August 23, 2014. [Cited: April 8, 2015.] http://www.drugs.com/venlafaxine.html.
  180. --. Fluoxetine. Drugs.com. [Online] August 26, 2014. [Cited: April 8, 2015.] http://www.drugs.com/fluoxetine.html.
  181. Scientific Opinion on the re-evaluation of curcumin (E 100) as a food additive. EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS). 9, Parma: European Food Safety Authority, September 10, 2010, EFSA Journal, Vol. 8, pp. 1679-1715. EFSA-Q-2008-220.
  182. National Toxicology Program. NTP Technical Report on the Toxicology and Carcinogenesis Studies of Turmeric Oleoresin (CAS No. 8024-37-1). U.S. Department of Health and Human Services. [Online] August 1993. [Cited: April 8, 2015.] http://ntp.niehs.nih.gov/ntp/htdocs/LT_rpts/tr427.pdf. NTP TR 427; NIH Publication No. 93-3158.
  183. Aromatic-turmerone induces neural stem cell proliferation in vitro and in vivo. Hucklenbroich, Joerg, et al., et al. [ed.] Rocky S. Tuan and Timothy O'Brien. 4, Pittsburgh; Galway: BioMed Central Ltd, September 26, 2014, Stem Cell Research & Therapy , Vol. 5, p. 100. DOI: 10.1186/scrt500; http://stemcellres.biomedcentral.com/articles/10.1186/scrt500. ISSN: 1757-6512; PMID: 25928248.
  184. Composition and Antioxidant Properties of Essential Oils from Curcuma rhizome. Tsai, Snu-Yao, et al., et al. [ed.] Shian-Shyong Tseng. 1, Taichung City: Asia University, June 2011, Asian Journal of Arts and Sciences, Vol. 2, pp. 57-66. ISSN: 2221-4224.
  185. Hopper, Leigh. Curcumin improves memory and mood, new UCLA study says. UCLA Newsroom. [Online] January 22, 2018. [Cited: January 29, 2018.] http://newsroom.ucla.edu/releases/curcumin-improves-memory-and-mood-new-ucla-study-says.
  186. Memory and Brain Amyloid and Tau Effects of a Bioavailable Form of Curcumin in Non-Demented Adults: A Double-Blind, Placebo-Controlled 18-Month Trial. Small, Gary W., et al., et al. [ed.] III Charles F. Reynolds. 30511-0; In Press, Corrected Proof, Pittsburgh: Elsevier Inc., October 27, 2017, The American Journal of Geriatric Psychiatry, Vol. 17, pp. pii: S1064-7481. DOI: 10.1016/j.jagp.2017.10.010; http://linkinghub.elsevier.com/retrieve/pii/S1064748117305110. ISSN: 1064-7481; PMID: 29246725. Presented in part at the 2017 Alzheimer's Association International Conference, London, UK.

Join the 1000s of People Who Are Discovering the Benefits of Turmeric.



New Vegan, Cruelty Free, Non GMO, Stearate Free, Gluten Free Turmeric Health Supplement Made in the USA in a GMP-certified, FDA-approved facility.

Healthceuticals® Turmeric Curcumin Complex

100% Certified
Organic ingredients

  • Organic Turmeric Extract - standardized to 95% curcuminoids.
  • Organic Whole Turmeric - provides full spectrum antioxidant, anti-inflammatory turmeric benefits, including turmerones and numerous vitamins, minerals, and phytonutrients
  • Organic Black Pepper Extract - standardized to 95% piperine; dramatically enhances bioavailablity.
  • Organic Phospholipids - markedly improve absorption.
  • Organic Ginger - works synergistically with turmeric to provide more powerful benefits.
  • Absolutely FREE of potentially harmful additives and fillers such as magnesium stearate.
Vegan | Cruelty Free | Non GMO | Stearate Free | Gluten Free Made in the USA in a GMP-certified, FDA-approved facility
Disclaimer: This website is not intended to replace professional consultation, diagnosis, or treatment by a licensed physician. If you require any medical related advice, contact your physician promptly. Information at this website is exclusively of a general reference nature. Do not disregard medical advice or delay treatment as a result of accessing information at this site.